Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/13/2008WO2007146306A3 Methods and compositions for improving cognitive function
11/13/2008WO2007145991A3 Anti-inflammatory and analgesic compositions and related methods
11/13/2008WO2007145563A8 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
11/13/2008WO2007133560A9 Acetylenic heteroaryl compounds
11/13/2008WO2007131219A3 Cannabinoid receptor antagonists/inverse agonists
11/13/2008WO2007125429A3 Method for the synthesis of triazole- containing oligonucleotide derivatives
11/13/2008WO2007124353A3 Antispermatogenic, spermicidal and/or antifungal composition and methods of using the same
11/13/2008WO2007124132A3 Polymeric compositions and methods of making and using thereof
11/13/2008WO2007124104A3 Needle-free delivery of hiv therapeutics
11/13/2008WO2007122369A8 Novel tumour suppressor
11/13/2008WO2007121299A3 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
11/13/2008WO2007121188A3 Compositions and methods of using r(+) pramipexole
11/13/2008WO2007120485A3 Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor
11/13/2008WO2007117432A3 Methods and compositions for modulating angiogenesis and tumor growth
11/13/2008WO2007117394A3 Compositions and methods related to fructosamine-3-kinase inhibitors
11/13/2008WO2007113885A8 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
11/13/2008WO2007112173A3 Method for promoting composite tissue regeneration and uses thereof
11/13/2008WO2007102037A3 A PROCESS FOR THE PREPARATION OF POLYMORPH FORM I OF (S)-(+)-METHYL-α-(2-CHLOROPHENYL)-6,7-DYHIDRO-THIENO-[3,2-c]PYRIDINE-5(4H)-ACETATE HYDROGEN SULFATE
11/13/2008WO2007100576A3 Compositions and methods for repressing the ink4a and arf senescence pathways
11/13/2008WO2007079394A3 Arginine heteromers for topical administration
11/13/2008WO2007056279A3 Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors
11/13/2008WO2006137838A3 Methods and compositions for diagnosing and preventing a group b streptococcal infection
11/13/2008WO2006118821A3 Systems and methods for treating human inflammatory and proliferative diseases, with a combination of compounds, or a bifunctional compound,that provides fatty acid metabolism and glycolysis inhibition
11/13/2008WO2005084323A3 Compositions of bio-active compounds from fenugreek seed and methods for producing same
11/13/2008US20080281236 Devices and methodologies useful in body aesthetics
11/13/2008US20080281111 Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
11/13/2008US20080281092 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
11/13/2008US20080280996 Rheumatic diseases; antiarthritic agents; osteoarthritis; lupus; inflammatory bowel disorders; psoriasis; atherosclerosis; cyclooxygenase inhibitor; antidepressants; blocks production of cytokines, tumor necrosis factor, prostaglandins
11/13/2008US20080280995 Extracts of Latex of Calotropis Procera and to a Method of Preparation Thereof
11/13/2008US20080280994 Brown seaweed that has pharmacological properties ; glucosidase inhibitor; reducing blood glucose concentration; antidiabetic agents; obesity; free radical scavenger; activation macrophages; moderating nitric acid production
11/13/2008US20080280993 Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine
11/13/2008US20080280991 Substituted naphthalenes
11/13/2008US20080280990 administering -[(1-RS, 2-SR)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]-benzamide or isomers for the treatment of pain and as agents for treating or modulating central nervous system disorders
11/13/2008US20080280989 Hydroxybenzamide Derivatives, the Method For Preparing Thereof and the Cosmetic Composition Containing the Same
11/13/2008US20080280987 Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
11/13/2008US20080280986 Also prevention of pulmonary fibrosis; prodrug; sustained release form; injection, inhaled or oral form
11/13/2008US20080280985 Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of Diabetes
11/13/2008US20080280984 Transdermal Delivery of Beneficial Substances Effected By a Hostile Biophysical Environment
11/13/2008US20080280983 Methods of treating rett syndrome
11/13/2008US20080280982 3-{4-[1-(4'-tert-Butyl-biphenyl-4-ylmethyl)-3-methyl-butyl]-benzoylamino}-propionic acid, used as hypoglycemic agents of for the treatment of metabolic disorders such as diabetes
11/13/2008US20080280981 Oral dosage form; controlling blood concentration; urogenital disorders; edema; blood coagulation disorders in patient undergoing dental surgery
11/13/2008US20080280980 Treatment and Prevention of Bone Loss Using Resolvins
11/13/2008US20080280979 Methods and Compositions of Derivatives of Probucol for the Treatment of Diabetes
11/13/2008US20080280977 Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
11/13/2008US20080280976 Composition Comprising the Alcohol Compound Isolated from the Extract of Cucurbitaceae Family Plant Having Anti-Adipogenic and Anti-Obesity Activity
11/13/2008US20080280975 Administering mixture of serotonine receptor and serotonine receptor antagonist
11/13/2008US20080280974 Spiro compounds for treatment of inflammatory disorders
11/13/2008US20080280973 Laulimalide Analogues as Therapeutic Agents
11/13/2008US20080280972 Iminosugar treatment of tumors
11/13/2008US20080280971 deuterated (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid, used for the treatment of dyslipidemia and/or hyperlipemia
11/13/2008US20080280970 Deuterium-enriched atorvastatin
11/13/2008US20080280969 (5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide; neuropathic or inflammatory pain; modulation of use-dependent voltage-gated sodium channels
11/13/2008US20080280968 Bactericides; vision defects; diphtheria; Escherichia; skin disorders; Lyme disease; drug resistant Staphylococcus; respiratory system disorders; pneumonia; sepsis; urogenital disorders;trtanus; toxic shock syndrome; diarrhea; tuberculosis; typhoid; malaria; antiprotozoa agents
11/13/2008US20080280967 Antiarthritic agents; antiinflammatory agents; inflammatory bowel disorders; graft verses host disease; antiulcer agents; skin disorders; respiratory system disorders; anticancer agents
11/13/2008US20080280966 Emesis, urinary incontinence, depression, and anxiety; substance P inhibitors; 5-{1-[3,5-bis(Trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-1H-isoindole
11/13/2008US20080280965 Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs)
11/13/2008US20080280964 Novel Antibiotics Comprising Bis(1-Aryl-5-Tetrazolyl)Methane Derivatives
11/13/2008US20080280963 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/13/2008US20080280962 Novel thiazolidin-4-one derivatives
11/13/2008US20080280961 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/13/2008US20080280959 Cyclic n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for the therapeutic use thereof
11/13/2008US20080280958 Administering a phosphodiesterase inhibitor; bioavailability; skin disorders; respiratory system disorders; using roflumilast
11/13/2008US20080280957 Heterocyclic Inhibitors of Mek and Methods of Use Thereof
11/13/2008US20080280956 Heteroarylsulfonyl Stilbenes as 5-Ht2a Antagonists
11/13/2008US20080280955 Methods and compositions for screening and treatment of disorders of blood glucose regulation
11/13/2008US20080280954 Method of Improving Wakefulness
11/13/2008US20080280952 Pyridine Derivatives as Connabinoid Receptor Modulators
11/13/2008US20080280951 Salt Il
11/13/2008US20080280950 Hydantoin Derivatives Useful as Metalloproteinase Inhibitors
11/13/2008US20080280949 Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators
11/13/2008US20080280948 Modulators of amyloid beta
11/13/2008US20080280947 Anti-insomnia compositions and methods
11/13/2008US20080280946 Azaindole-Derivatives As Factor Xa Inhibitors
11/13/2008US20080280945 Crystalline forms of an HIV integrase inhibitor
11/13/2008US20080280944 Sleep disorders; administering a potassium channel moderator
11/13/2008US20080280943 Methods and packages to enhance safety when using imiquimod to treat children diagnosed with skin disorders
11/13/2008US20080280942 Tetrahydro-Beta-Carbolin-Sulfonamide Derivatives as 5-Ht6 Ligands
11/13/2008US20080280941 8-Phenoxy-Gamma Carboline Derivatives
11/13/2008US20080280940 Rapamycin Derivative or an Impdh Inhibitor For Treating Polycystic Kidney Disease
11/13/2008US20080280939 Combination of Organic Compounds
11/13/2008US20080280938 Screening Method
11/13/2008US20080280937 Ligand Conjugates of Vinca Alkaloids, Analogs, and Derivatives
11/13/2008US20080280936 Morphinan Compounds
11/13/2008US20080280935 Process to Prepare Camptothecin Derivatives
11/13/2008US20080280934 Porphyrin ring compound containing cyanovinyl group; reacted with Vilsmeier reagent,complexed with metal ion in prsence of an acid and oxidizer; skin disorders; antiinflammatory agents; anticancer agents; antitumor agents; vascular disorders, vision defects, urogenital system disorders; immunology
11/13/2008US20080280933 Benzimidazolyl compounds
11/13/2008US20080280932 Synergistic mixture of inosine monophosphate dehydrogenasr inhibitor and hydroxy-3-methylglutaryl coenzyme a reductase inhibitor; low dosage; transplant rejection therapy, atherosclerosis, cardiovascular disorders, lupus, irritable bowel disorders, Crohn'd disease, antidiabetic agents, rheumatic diseases
11/13/2008US20080280931 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
11/13/2008US20080280930 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors such as tert-butyl 7-[4'-(4''-fluorophenyl)-6'-isopropyl-2'-oxo-3'-methyl-pyrimidin-5'-yl]-(3,5-)dihydroxyl-hept-6-enoate, useful for preventing and treating alzheimer's disease, diabetes, osteoporosis, tumors, cardiovascular and brain disorders
11/13/2008US20080280928 Pyrrolopyrimidine and Pyrrolopyridine Derivatives Substituted with a Cyclic Amino Group As Crf Antagonists
11/13/2008US20080280927 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
11/13/2008US20080280926 Phosphodiesterase Inhibitors
11/13/2008US20080280925 Amines as Small Molecule Inhibitors
11/13/2008US20080280924 Pyridine and pyrimidine derivatives as mglur2 antagonists
11/13/2008US20080280923 1-Benzylindole-2-Carboxamide Derivatives
11/13/2008US20080280922 Drug mixture containing apoliprotein and mitrosomal triglyceride transfer protrein inhibitor; veterinary medicine
11/13/2008US20080280921 Amorphous Aripiprazole and Process for the Preparation thereof
11/13/2008US20080280920 Plasminogen Activator Inhibitor-1 Inhibitors
11/13/2008US20080280919 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
11/13/2008US20080280918 phosphodiesterase enzyme inhibitor; 4-[(3-chlorophenyl)amino]-2-ethyl-5-(1-hydroxyethyl)-6-phenylpyridazin-3(2H)-one; potent antiinflammatory agent; asthma, atopic dermatitis, psoriasis, chronic obstructive pulmonary disease, rheumatoid arthritis, irritable bowel disease
1 ... 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 3010 3011 3012 3013 3014 3015 3016 3017 ... 7860